Pearl River Capital’s Quest Diagnostics DGX Stock Holding History

Pearl River Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,683	Closed	-$1.2M	–	523
2022 Q4	$1.2M	Buy	7,683 +439	+6%	+$63.1K	0.2%	161
2022 Q3	$889K	Buy	7,244 +1,336	+23%	+$176K	0.17%	186
2022 Q2	$786K	Buy	+5,908	New	+$805K	0.18%	176
2021 Q3	–	Sell	-1,664	Closed	-$220K	–	448
2021 Q2	$220K	Sell	1,664 -8,681	-84%	-$1.14M	0.06%	381
2021 Q1	$1.33M	Sell	10,345 -1,650	-14%	-$203K	0.42%	59
2020 Q4	$1.43M	Buy	11,995 +979	+9%	+$119K	0.51%	49
2020 Q3	$1.26M	Buy	+11,016	New	+$1.3M	0.53%	50
2019 Q3	–	Sell	-278	Closed	-$28K	–	444
2019 Q2	$28K	Buy	+278	New	+$26.7K	0.18%	173
2019 Q1	–	Sell	-720	Closed	-$60K	–	450
2018 Q4	$60K	Buy	+720	New	+$67.5K	0.28%	102

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pearl River Capital's DGX Position: Q1 2023 in Review

Pearl River Capital sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 7,683 shares — an estimated $1.2M sold.

Pearl River Capital first reported a position in DGX in Q4 2018 and held it in 9 quarters. The position peaked at $1.43M in Q4 2020. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

Pearl River Capital reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
Pearl River Capital sold 7,683 Quest Diagnostics shares in Q1 2023, an estimated $1.2M.
Pearl River Capital first reported a position in Quest Diagnostics in Q4 2018 and held it in 9 quarters.
Pearl River Capital's Quest Diagnostics position peaked at $1.43M in Q4 2020.
834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on Pearl River Capital's 13F filing for Q1 2023, filed 12 May 2023.